Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands |
Total |
Total Stockholders' Equity |
Common Stock |
Additional Paid In Capital |
Distributions in Excess of Cumulative Earnings |
Accumulated Other Comprehensive Income (Loss) |
Non-controlling Interests |
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
187,537,592
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
$ 3,572,127
|
$ 3,563,678
|
$ 1,875
|
$ 3,658,219
|
$ (113,302)
|
$ 16,886
|
$ 8,449
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Common stock issuance and OP Unit issuance (in shares) |
|
|
9,732,006
|
|
|
|
|
| Common stock issuance and OP Unit issuance |
278,623
|
278,623
|
$ 97
|
278,526
|
|
|
|
| Common stock withheld related to net share settlement of equity awards |
(6,300)
|
(6,300)
|
|
|
(6,300)
|
|
|
| Costs related to issuance of common stock |
(443)
|
(443)
|
|
(443)
|
|
|
|
| Other comprehensive income |
(22,364)
|
(22,295)
|
|
|
|
(22,295)
|
(69)
|
| Equity-based compensation expense (in shares) |
|
|
242,718
|
|
|
|
|
| Equity-based compensation expense |
3,968
|
3,968
|
$ 2
|
3,966
|
|
|
|
| Dividends and distributions declared |
(58,655)
|
(58,368)
|
|
|
(58,368)
|
|
(287)
|
| Net income |
56,281
|
56,108
|
|
|
56,108
|
|
173
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
197,512,316
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
3,823,237
|
3,814,971
|
$ 1,974
|
3,940,268
|
(121,862)
|
(5,409)
|
8,266
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
187,537,592
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
3,572,127
|
3,563,678
|
$ 1,875
|
3,658,219
|
(113,302)
|
16,886
|
8,449
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Other comprehensive income |
(37,629)
|
|
|
|
|
|
|
| Net income |
185,453
|
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2025 |
|
|
198,144,552
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
3,844,482
|
3,836,505
|
$ 1,981
|
3,967,376
|
(112,224)
|
(20,628)
|
7,977
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
197,512,316
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
3,823,237
|
3,814,971
|
$ 1,974
|
3,940,268
|
(121,862)
|
(5,409)
|
8,266
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Common stock issuance and OP Unit issuance (in shares) |
|
|
604,104
|
|
|
|
|
| Common stock issuance and OP Unit issuance |
20,186
|
20,186
|
$ 6
|
20,180
|
|
|
|
| Common stock withheld related to net share settlement of equity awards |
(7)
|
(7)
|
|
|
(7)
|
|
|
| Costs related to issuance of common stock |
(45)
|
(45)
|
|
(45)
|
|
|
|
| Other comprehensive income |
(12,416)
|
(12,382)
|
|
|
|
(12,382)
|
(34)
|
| Equity-based compensation expense (in shares) |
|
|
22,147
|
|
|
|
|
| Equity-based compensation expense |
3,497
|
3,497
|
$ 1
|
3,496
|
|
|
|
| Dividends and distributions declared |
(59,836)
|
(59,544)
|
|
|
(59,544)
|
|
(292)
|
| Net income |
63,370
|
63,212
|
|
|
63,212
|
|
158
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
198,138,567
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
3,837,986
|
3,829,888
|
$ 1,981
|
3,963,899
|
(118,201)
|
(17,791)
|
8,098
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Common stock issuance and OP Unit issuance |
0
|
|
|
|
|
|
|
| Common stock withheld related to net share settlement of equity awards |
(100)
|
(100)
|
|
|
(100)
|
|
|
| Costs related to issuance of common stock |
(76)
|
(76)
|
|
(76)
|
|
|
|
| Other comprehensive income |
(2,845)
|
(2,837)
|
|
|
|
(2,837)
|
(8)
|
| Equity-based compensation expense (in shares) |
|
|
5,985
|
|
|
|
|
| Equity-based compensation expense |
3,553
|
3,553
|
|
3,553
|
|
|
|
| Dividends and distributions declared |
(59,836)
|
(59,543)
|
|
|
(59,543)
|
|
(293)
|
| Net income |
65,800
|
65,620
|
|
|
65,620
|
|
180
|
| Ending balance (in shares) at Sep. 30, 2025 |
|
|
198,144,552
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
$ 3,844,482
|
3,836,505
|
$ 1,981
|
3,967,376
|
(112,224)
|
(20,628)
|
7,977
|
| Beginning balance (in shares) at Dec. 31, 2025 |
209,702,433
|
|
209,702,433
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
$ 4,207,894
|
4,199,994
|
$ 2,097
|
4,328,137
|
(109,261)
|
(20,979)
|
7,900
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Common stock issuance and OP Unit issuance (in shares) |
|
|
6,231,352
|
|
|
|
|
| Common stock issuance and OP Unit issuance |
192,725
|
192,725
|
$ 62
|
192,663
|
|
|
|
| Common stock withheld related to net share settlement of equity awards |
(8,181)
|
(8,181)
|
|
|
(8,181)
|
|
|
| Costs related to issuance of common stock |
(463)
|
(463)
|
|
(463)
|
|
|
|
| Other comprehensive income |
8,576
|
8,552
|
|
|
|
8,552
|
24
|
| Equity-based compensation expense (in shares) |
|
|
312,170
|
|
|
|
|
| Equity-based compensation expense |
4,129
|
4,129
|
$ 3
|
4,126
|
|
|
|
| Dividends and distributions declared |
(67,576)
|
(67,123)
|
|
|
(67,123)
|
|
(453)
|
| Net income |
59,950
|
59,792
|
|
|
59,792
|
|
158
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
|
216,245,955
|
|
|
|
|
| Ending balance at Mar. 31, 2026 |
$ 4,397,054
|
4,389,425
|
$ 2,162
|
4,524,463
|
(124,773)
|
(12,427)
|
7,629
|
| Beginning balance (in shares) at Dec. 31, 2025 |
209,702,433
|
|
209,702,433
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
$ 4,207,894
|
4,199,994
|
$ 2,097
|
4,328,137
|
(109,261)
|
(20,979)
|
7,900
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Other comprehensive income |
39,169
|
|
|
|
|
|
|
| Net income |
$ 195,088
|
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2026 |
220,275,169
|
|
220,275,169
|
|
|
|
|
| Ending balance at Sep. 30, 2026 |
$ 4,584,224
|
4,540,900
|
$ 2,203
|
4,651,877
|
(131,154)
|
17,974
|
43,324
|
| Beginning balance (in shares) at Mar. 31, 2026 |
|
|
216,245,955
|
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
4,397,054
|
4,389,425
|
$ 2,162
|
4,524,463
|
(124,773)
|
(12,427)
|
7,629
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Common stock issuance and OP Unit issuance |
36,569
|
0
|
|
|
|
|
36,569
|
| Costs related to issuance of common stock |
(93)
|
(93)
|
|
(93)
|
|
|
|
| Other comprehensive income |
10,781
|
10,753
|
|
|
|
10,753
|
28
|
| Equity-based compensation expense (in shares) |
|
|
26,003
|
|
|
|
|
| Equity-based compensation expense |
3,331
|
3,331
|
$ 1
|
3,330
|
|
|
|
| Dividends and distributions declared |
(70,152)
|
(69,292)
|
|
|
(69,292)
|
|
(860)
|
| Net income |
74,481
|
74,287
|
|
|
74,287
|
|
194
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
|
216,271,958
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
4,451,971
|
4,408,411
|
$ 2,163
|
4,527,700
|
(119,778)
|
(1,674)
|
43,560
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Common stock issuance and OP Unit issuance (in shares) |
|
|
3,969,568
|
|
|
|
|
| Common stock issuance and OP Unit issuance |
119,503
|
119,503
|
$ 40
|
119,463
|
|
|
|
| Common stock withheld related to net share settlement of equity awards |
(964)
|
(964)
|
|
|
(964)
|
|
|
| Costs related to issuance of common stock |
(292)
|
(292)
|
|
(292)
|
|
|
|
| Other comprehensive income |
19,812
|
19,648
|
|
|
|
19,648
|
164
|
| Equity-based compensation expense (in shares) |
|
|
33,643
|
|
|
|
|
| Equity-based compensation expense |
5,006
|
5,006
|
|
5,006
|
|
|
|
| Dividends and distributions declared |
(71,469)
|
(70,569)
|
|
|
(70,569)
|
|
(900)
|
| Net income |
$ 60,657
|
60,157
|
|
|
60,157
|
|
500
|
| Ending balance (in shares) at Sep. 30, 2026 |
220,275,169
|
|
220,275,169
|
|
|
|
|
| Ending balance at Sep. 30, 2026 |
$ 4,584,224
|
$ 4,540,900
|
$ 2,203
|
$ 4,651,877
|
$ (131,154)
|
$ 17,974
|
$ 43,324
|